TP53 and thyroid gland carcinoma: Furthermore, GX15-070 has recently shown anti-tumor effects in two mouse cell lines derived from mice with thyroid-specific activation of Kras and deletion of p53, which develop PTC and subsequently poorly differentiated thyroid carcinoma and ATC and one human ATC cell line [53].